IL1B and COVID-19: Furthermore, this synergistic combination of acetate and ALA significantly increased the expression of host interferon-β (IFN-β) and decreased the expression of host interleukins IL-1β and IL-6, which are associated with severe COVID-19 (Figure 1I–K).